Join us in-person for the 2025 DTRF "Together We Will" Weekend in Chicago from Sept. 12-13! - Register Today

Jonathan Noujaim, MD, CanSaRCC

“Tyrosine kinase inhibitors in desmoid-type fibromatosis- a Canadian multicenter retrospective CanSaRCC Study.” Year 1 of 1

Jointly funded by the DTRF and Desmoid Tumour Foundation of Canada (DFC)